22YF1445000/Shanghai Sailing Program[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2023	1
2024	3
2025	0

Page 1

Progress in RAS-targeted therapeutic strategies: From small molecule inhibitors to proteolysis targeting chimeras.

Lu X, Jin J, Wu Y, Liu X, Liang X, Lin J, Sun Q, Qin J, Zhang W, Luan X. Lu X, et al. Med Res Rev. 2024 Mar;44(2):812-832. doi: 10.1002/med.21993. Epub 2023 Nov 27. Med Res Rev. 2024. PMID: 38009264 Review.

Oncolytic Peptide-Nanoplatform Drives Oncoimmune Response and Reverses Adenosine-Induced Immunosuppressive Tumor Microenvironment.

Wu Y, Lin JY, Zhou YD, Liu HJ, Lu SX, Zhang XK, Guan YY, Nagle DG, Zhang WD, Chen HZ, Luan X. Wu Y, et al. Adv Healthc Mater. 2024 Oct;13(26):e2303445. doi: 10.1002/adhm.202303445. Epub 2024 Jul 9. Adv Healthc Mater. 2024. PMID: 38290499

In Silico Discovery of Stapled Peptide Inhibitor Targeting the Nur77-PPARγ Interaction and Its Anti-Breast-Cancer Efficacy.

Bian H, Liang X, Lu D, Lin J, Lu X, Jin J, Zhang L, Wu Y, Chen H, Zhang W, Luan X. Bian H, et al. Adv Sci (Weinh). 2024 Jul;11(26):e2308435. doi: 10.1002/advs.202308435. Epub 2024 Apr 29. Adv Sci (Weinh). 2024. PMID: 38682467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year